Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Alcohol-associated liver disease is associated with less adverse outcomes compared to nonalcohol-associated liver disease in patients with COVID-19.
Journal: Alcohol, clinical & experimental research
Published: February 11, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ Transplant.
Journal: The Annals of pharmacotherapy
Published: January 16, 2025
Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection.
Journal: Transplantation proceedings
Published: December 27, 2024
Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2.
Journal: World journal of virology
Published: April 06, 2024
Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-Resistance.
Journal: Clinical transplantation
Published: February 19, 2024
Infective endocarditis is rare in patients with hematologic malignancy and neutropenia.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: January 04, 2024
Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience.
Journal: Critical care research and practice
Published: December 28, 2023
Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
Journal: Transplantation proceedings
Published: December 17, 2023
A call for cytomegalovirus stewardship initiatives in cardiothoracic transplant.
Journal: JHLT open
Published: November 08, 2023
Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients.
Journal: The Annals of pharmacotherapy
Published: October 28, 2023
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction.
Journal: Clinical transplantation
Published: July 26, 2023
Last Updated: 09/26/2026